doxepin has been researched along with Depressive Disorder in 124 studies
Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Forty patients with major depressive disorder (according to DSM-III-R criteria) were enrolled in a 6-week double-blind parallel group study of fluoxetine (N = 20) or doxepin (N = 20)." | 9.08 | Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder. ( Baker, B; Dorian, P; Irvine, MJ; Mitchell, J; Sandor, P; Schell, C; Shapiro, C, 1997) |
| "Sixty patients with chronic pain of the low back or cervical spine concomitant with clinical depression were studied in a 6-week, randomized, double-blind comparison of doxepin and placebo." | 9.05 | Doxepin's effects on chronic pain and depression: a controlled study. ( Cork, RC; Crago, BR; Davis, TP; Hameroff, SR; Lerman, JC; Neuman, CP; Watts, KS; Weiss, JL; Womble, JR, 1984) |
| "Doxepin and desipramine at final doses of 188 and 173 mg/day, respectively, were compared in 36 volunteers with major affective or dysthymic disorder and chronic back pain." | 9.05 | Antidepressants in concomitant chronic back pain and depression: doxepin and desipramine compared. ( Benedetti, C; Bokan, JA; Butler, S; Phillips, M; Spengler, D; Ward, N, 1984) |
| "A 46-year-old man suffering from neurotic depression complicated by alcohol and benzodiazepine dependence developed Coombs'-positive hemolytic anemia and thrombocytopenia with acute renal failure after 5 weeks of monotherapy with doxepin at a final dosage of 100 mg daily." | 7.67 | A case of immune complex hemolytic anemia, thrombocytopenia, and acute renal failure associated with doxepin use. ( Conradty, M; Grohmann, R; Londong, V; Rüther, E; Witzgall, H; Wolf, B, 1989) |
| "A group of patients with both depression and chronic pain were treated with doxepin for 4 weeks." | 7.66 | Urinary 3-methoxy-4-hydroxyphenethylene glycol in the prediction of pain and depression relief with doxepin: preliminary findings. ( Bloom, VL; Fawcett, J; Friedel, RO; Ward, NG, 1983) |
| "A 66-year-old woman had tinnitus while receiving a conventional dose of doxepin." | 7.66 | Doxepin and tinnitus. ( Evans, DL; Golden, RN; Nau, CH, 1983) |
| "A case is described of ventricular arrhythmias associated with doxepin and amitriptyline treatment in a patient with preexisting heart disease." | 7.66 | Ventricular arrhythmias induced by doxepin and amitriptyline: case report. ( Faber, R; Todd, RD, 1983) |
| "Average maximum daily dosage was 83 mg/d in the control and 95 mg/d in the intervention group (F=19." | 6.73 | A randomized controlled clinical trial comparing "guideline exposed" and "guideline naive" physicians in respect to dosage selection and treatment outcome with doxepin in depressive disorders. ( Linden, M; Schotte, K, 2007) |
| "Fluoxetine was compared to doxepin in geriatric out-patients with major depressive illness." | 6.66 | Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. ( Cohn, JB; Feighner, JP, 1985) |
| " Forty patients with major depressive disorder (according to DSM-III-R criteria) were enrolled in a 6-week double-blind parallel group study of fluoxetine (N = 20) or doxepin (N = 20)." | 5.08 | Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder. ( Baker, B; Dorian, P; Irvine, MJ; Mitchell, J; Sandor, P; Schell, C; Shapiro, C, 1997) |
| "After controlled treatment with either imipramine or doxepin with additional psychotherapy, 30 patients with pure panic disorder and 20 with concomitant depression were followed under ordinary treatment conditions over a 5-year period." | 5.08 | Fluctuation of symptoms and social functioning in panic disorder with or without concomitant depression. A 5-year prospective follow-up. ( Albus, M; Scheibe, G; Scherer, J, 1995) |
| "50 patients with panic disorder (30 without and 20 with concomitant depression) were enrolled in a controlled treatment study using either imipramine or doxepin in addition to supportive psychotherapy and were then studied under naturalistic treatment conditions over a 5-year period." | 5.08 | Panic disorder with or without concomitant depression 5 years after treatment: a prospective follow-up. ( Albus, M; Scheibe, G; Scherer, J, 1995) |
| "Patients with chronic low-back pain and depression were treated double blind with desipramine or doxepin." | 5.06 | Tricyclic antidepressants for chronic low-back pain. Mechanisms of action and predictors of response. ( Ward, NG, 1986) |
| "The efficacy of low doses (10 to 20 mg daily) of doxepin in the treatment of depressive disorders in elderly inpatients was assessed by a double-blind study in 24 patients." | 5.06 | Effective low dose tricyclic antidepressant treatment for depressed geriatric rehabilitation patients. A double-blind study. ( Frengley, JD; Lakshmanan, M; Mion, LC, 1986) |
| "Sixty patients with chronic pain of the low back or cervical spine concomitant with clinical depression were studied in a 6-week, randomized, double-blind comparison of doxepin and placebo." | 5.05 | Doxepin's effects on chronic pain and depression: a controlled study. ( Cork, RC; Crago, BR; Davis, TP; Hameroff, SR; Lerman, JC; Neuman, CP; Watts, KS; Weiss, JL; Womble, JR, 1984) |
| "Doxepin and desipramine at final doses of 188 and 173 mg/day, respectively, were compared in 36 volunteers with major affective or dysthymic disorder and chronic back pain." | 5.05 | Antidepressants in concomitant chronic back pain and depression: doxepin and desipramine compared. ( Benedetti, C; Bokan, JA; Butler, S; Phillips, M; Spengler, D; Ward, N, 1984) |
| "To address this issue, the authors studied the cardiovascular effects of doxepin in 32 depressed patients with preexisting left ventricular impairment, ventricular arrhythmias, and/or conduction disease." | 3.68 | Is doxepin a safer tricyclic for the heart? ( Dalack, GW; Giardina, EG; Glassman, AH; Roose, SP; Walsh, BT; Woodring, S, 1991) |
| "A 46-year-old man suffering from neurotic depression complicated by alcohol and benzodiazepine dependence developed Coombs'-positive hemolytic anemia and thrombocytopenia with acute renal failure after 5 weeks of monotherapy with doxepin at a final dosage of 100 mg daily." | 3.67 | A case of immune complex hemolytic anemia, thrombocytopenia, and acute renal failure associated with doxepin use. ( Conradty, M; Grohmann, R; Londong, V; Rüther, E; Witzgall, H; Wolf, B, 1989) |
| "A 66-year-old woman had tinnitus while receiving a conventional dose of doxepin." | 3.66 | Doxepin and tinnitus. ( Evans, DL; Golden, RN; Nau, CH, 1983) |
| "A case is described of ventricular arrhythmias associated with doxepin and amitriptyline treatment in a patient with preexisting heart disease." | 3.66 | Ventricular arrhythmias induced by doxepin and amitriptyline: case report. ( Faber, R; Todd, RD, 1983) |
| "A group of patients with both depression and chronic pain were treated with doxepin for 4 weeks." | 3.66 | Urinary 3-methoxy-4-hydroxyphenethylene glycol in the prediction of pain and depression relief with doxepin: preliminary findings. ( Bloom, VL; Fawcett, J; Friedel, RO; Ward, NG, 1983) |
| "Average maximum daily dosage was 83 mg/d in the control and 95 mg/d in the intervention group (F=19." | 2.73 | A randomized controlled clinical trial comparing "guideline exposed" and "guideline naive" physicians in respect to dosage selection and treatment outcome with doxepin in depressive disorders. ( Linden, M; Schotte, K, 2007) |
| " Patients were treated with either amitriptyline (n = 69) or doxepin (n = 15); the mean dosage at endpoint was 126 +/- 35 mg and 155 +/- 47 mg, respectively." | 2.71 | Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions? ( Dragicevic, A; Fric, M; Gaertner, I; Grasmäder, K; Härtter, S; Hermann, E; Hiemke, C; Kuss, HJ; Laux, G; Müller, MJ; Oehl, W; Rao, ML; Rollmann, N; Weber-Labonte, M; Weigmann, H, 2003) |
| "In the treatment of depressive disorders the onset of action can be accelerated if the antidepressant drug is initially administered by intravenous infusion." | 2.68 | On the problems of switching from intravenous to oral administration in drug treatment of endogenous depression--a placebo-controlled double-blind trial with doxepin. ( Adler, L; Böke, J; Hajak, G; Hoffmann, G; Huether, G; Issinger, J; Kunert, HJ; Lehmann, K; Rüther, E, 1997) |
| "Placebo for 1 week, 2 weeks of titration with either drug in the dosage range of 75 mg/day up to a maximum of 200 mg/day." | 2.67 | A comparison of the cardiac safety and therapeutic efficacy of trimipramine versus doxepin in geriatric depressed patients. ( Amin, M; Dastoor, D; MacDonald, C; Mirmiran, J; Nair, NP; Phillips, R; Schwartz, G; Thavundayil, JX, 1993) |
| " Two groups of 22 patients each received amitriptylinoxide and doxepine respectively at a daily dosage of 120-360 mg for a period of 4 weeks." | 2.67 | A double-blind comparison of amitriptylinoxide versus doxepine in the treatment of severe depression. ( Diehl, B; Heinrich, T; König, W, 1994) |
| "Paroxetine is an antidepressant that acts through selective inhibition of serotonin reuptake." | 2.67 | Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. ( Cohn, CK; Cohn, JB; Dunner, DL; Feighner, JP; Fieve, RR; Halikas, JP; Hartford, JT; Hearst, ED; Settle, EC; Walshe, T, 1992) |
| "The increased orthostatic hypotension occurred early in treatment and at low doses of imipramine." | 2.66 | Orthostatic effect of imipramine and doxepin in depressed geriatric outpatients. ( Aldrich, J; Conolly, ME; Gerner, R; Hill, M; Jarvik, LF; Joseph, J; Linde, S; Mintz, J; Neshkes, RE; Rosen, R, 1985) |
| "After a 1-week placebo washout, 25 depressed hospitalized patients were treated for 4 weeks with trimipramine or doxepin in a fixed equivalent dosage schedule ending in 150 mg h." | 2.66 | A comparative trial of the antidepressant, anxiolytic, and cardiovascular effects of trimipramine and doxepin in depressed hospitalized patients. ( Assalian, P; Phillips, R; Rosengarten, MD, 1985) |
| "Fluoxetine was compared to doxepin in geriatric out-patients with major depressive illness." | 2.66 | Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder. ( Cohn, JB; Feighner, JP, 1985) |
| "Doxepin was superior to placebo on Clinical Global Impressions and several factors of the Hamilton Rating Scale for Depression and the Profile of Mood States." | 2.65 | Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study. ( Barranco, M; Kyle, EM; Seco, G; Titievsky, J, 1982) |
| "Clomipramine was effective, safe, and well tolerated as compared to doxepin in the treatment of outpatients with neurotic depression." | 2.65 | A comparison of clomipramine and doxepin in neurotic depression. ( Horwitz, IM; Kornhaber, A, 1984) |
| "Maprotiline was associated with decreased PVCs in patients with a "high" baseline rate, while doxepin was associated with increased PVCs in this group." | 2.65 | Comparative cardiac effects of maprotiline and doxepin in elderly depressed patients. ( Ahles, S; Gwirtsman, H; Halaris, A; Hill, MA; Schwarcz, G; Shah, P, 1984) |
| " A significant positive correlation was obtained between dosage and blood levels of maprotiline and doxepin, but there was no correlation between blood levels and clinical response." | 2.65 | Therapeutic superiority of maprotiline versus doxepin in geriatric depression. ( Ahles, S; DeMet, E; Gwirtsman, HE; Halaris, A; Hill, MA, 1983) |
| "Treatment with imipramine and doxepin, but not placebo, was associated with significant improvement (P less than 0." | 2.65 | Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. ( Barnes, RF; Caldwell, JH; Gumbrecht, G; Raskind, MA; Ritchie, JL; Veith, RC, 1982) |
| " The plasma concentration of both doxepin and nordoxepin correlated significantly with the oral dosage of doxepin (doxepin: r = +0." | 1.37 | Doxepin concentrations in plasma and cerebrospinal fluid. ( Fassbender, K; Maurer, HH; Remane, D; Schomburg, R; Spiegel, J, 2011) |
| "Doctors' prescription and dosing behaviour was investigated using data from 9 clinical trials in 550 patients treated with psychotropics." | 1.29 | Correct titration of non-drugs and some other methodological issues. ( Beneke, M; Fritze, J; Rasmus, W; Rød, IS, 1994) |
| "Doxepin has gained favour for use in the geriatric population due to claims of low cardiovascular side effects." | 1.28 | Comparative plasma levels of doxepin and desipramine in the elderly. ( Ancill, RJ; Gosselin, C, 1989) |
| " Mean DMD t1/2 was not significantly affected by multiple dosing (34." | 1.27 | Multiple-dose doxepin kinetics in depressed patients. ( Fann, WE; Faulkner, RD; Lee, CS; Lewis, WA; Pitts, WM, 1983) |
| " Regardless of the reason for use, nonpsychiatric physicians were found to use relatively low dosages, rarely plan or effect dosage increases, and rarely discontinue medication." | 1.27 | Antidepressant treatment of medical-surgical inpatients by nonpsychiatric physicians. ( Callies, AL; Popkin, MK, 1987) |
| "Cerebrotendinous xanthomatosis is a genetically transmitted disease that is associated with deposition of cholestanol in the central nervous system and Achilles tendons." | 1.27 | Depression in a patient with dementia secondary to cerebrotendinous xanthomatosis. ( Shapiro, S, 1983) |
| "Desipramine was associated with a much higher frequency of jitteriness than was imipramine." | 1.27 | The jitteriness syndrome in panic disorder patients treated with antidepressants. ( Balon, R; Lycaki, H; Pohl, R; Yeragani, VK, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 79 (63.71) | 18.7374 |
| 1990's | 34 (27.42) | 18.2507 |
| 2000's | 8 (6.45) | 29.6817 |
| 2010's | 2 (1.61) | 24.3611 |
| 2020's | 1 (0.81) | 2.80 |
| Authors | Studies |
|---|---|
| Hashmi, HZ | 1 |
| Kaur, J | 1 |
| Stout, SC | 1 |
| Drake, T | 1 |
| Sun, Y | 1 |
| Liang, Y | 1 |
| Jiao, Y | 1 |
| Lin, J | 1 |
| Qu, H | 1 |
| Xu, J | 1 |
| Zhao, C | 1 |
| Schomburg, R | 1 |
| Remane, D | 1 |
| Fassbender, K | 1 |
| Maurer, HH | 1 |
| Spiegel, J | 1 |
| Müller, MJ | 1 |
| Dragicevic, A | 1 |
| Fric, M | 1 |
| Gaertner, I | 1 |
| Grasmäder, K | 1 |
| Härtter, S | 2 |
| Hermann, E | 1 |
| Kuss, HJ | 1 |
| Laux, G | 3 |
| Oehl, W | 1 |
| Rao, ML | 2 |
| Rollmann, N | 1 |
| Weigmann, H | 1 |
| Weber-Labonte, M | 1 |
| Hiemke, C | 2 |
| Labbate, LA | 1 |
| Croft, HA | 1 |
| Oleshansky, MA | 1 |
| Bajbouj, M | 1 |
| Gallinat, J | 1 |
| Lang, UE | 1 |
| Hellen, F | 1 |
| Vesper, J | 1 |
| Lisanby, SH | 1 |
| Danker-Hopfe, H | 1 |
| Neu, P | 1 |
| Linden, M | 1 |
| Schotte, K | 1 |
| Kiev, A | 1 |
| Feighner, JP | 4 |
| Ansseau, M | 1 |
| Ansoms, C | 1 |
| Beckers, G | 1 |
| Bogaerts, M | 1 |
| Botte, L | 1 |
| De Buck, R | 1 |
| Diricq, S | 1 |
| Dumortier, A | 1 |
| Jansegers, E | 1 |
| Owieczka, J | 1 |
| Ward, NG | 3 |
| Bloom, VL | 2 |
| Dworkin, S | 1 |
| Fawcett, J | 2 |
| Narasimhachari, N | 1 |
| Friedel, RO | 3 |
| Ahles, S | 2 |
| Gwirtsman, H | 1 |
| Halaris, A | 2 |
| Shah, P | 1 |
| Schwarcz, G | 1 |
| Hill, MA | 2 |
| Hameroff, SR | 1 |
| Weiss, JL | 1 |
| Lerman, JC | 1 |
| Cork, RC | 1 |
| Watts, KS | 1 |
| Crago, BR | 1 |
| Neuman, CP | 1 |
| Womble, JR | 1 |
| Davis, TP | 1 |
| Ward, N | 1 |
| Bokan, JA | 1 |
| Phillips, M | 1 |
| Benedetti, C | 1 |
| Butler, S | 1 |
| Spengler, D | 1 |
| Luchins, DJ | 1 |
| Jarvik, LF | 3 |
| Read, SL | 1 |
| Mintz, J | 3 |
| Neshkes, RE | 2 |
| Gwirtsman, HE | 1 |
| DeMet, E | 1 |
| Ayd, FJ | 2 |
| Kornhaber, A | 1 |
| Horwitz, IM | 1 |
| de Montigny, C | 1 |
| Cournoyer, G | 1 |
| Morissette, R | 1 |
| Langlois, R | 1 |
| Caillé, G | 1 |
| Schwab, JJ | 1 |
| Golden, RN | 1 |
| Evans, DL | 1 |
| Nau, CH | 1 |
| Faulkner, RD | 1 |
| Pitts, WM | 1 |
| Lee, CS | 1 |
| Lewis, WA | 1 |
| Fann, WE | 1 |
| Todd, RD | 1 |
| Faber, R | 1 |
| Freinhar, J | 1 |
| Rickels, K | 4 |
| Csanalosi, I | 1 |
| Werblowsky, J | 1 |
| Weise, CC | 2 |
| Weinstock, R | 1 |
| Brown, AS | 1 |
| Winokur, A | 1 |
| Von Poelnitz, M | 1 |
| Asnis, GM | 1 |
| Halbreich, U | 1 |
| Nathan, RS | 1 |
| Ostrow, L | 1 |
| Novacenko, H | 1 |
| Endicott, J | 1 |
| Sachar, EJ | 1 |
| Khan, MC | 1 |
| Bennie, EH | 1 |
| Stulemeijer, SM | 1 |
| Ravens, MA | 1 |
| Pishkin, V | 1 |
| Shurley, JT | 1 |
| Veith, RC | 2 |
| Raskind, MA | 2 |
| Barnes, RF | 2 |
| Gumbrecht, G | 2 |
| Ritchie, JL | 2 |
| Halter, JB | 1 |
| Dilsaver, SC | 2 |
| Domino, L | 1 |
| Hekimian, LJ | 1 |
| Friedhoff, AJ | 1 |
| Brunswick, DJ | 1 |
| Amsterdam, JD | 2 |
| Potter, L | 2 |
| Caroff, S | 2 |
| Shapiro, S | 1 |
| Friedman, J | 1 |
| McCallum, P | 1 |
| Meares, R | 1 |
| Woody, GE | 1 |
| O'Brien, CP | 1 |
| McLellan, AT | 1 |
| Marcovici, M | 1 |
| Evans, BD | 1 |
| McEvoy, JP | 2 |
| Sheridan, WF | 1 |
| Stewart, WR | 1 |
| Ban, TA | 2 |
| Wilson, WH | 2 |
| Guy, W | 2 |
| Schaffer, JD | 2 |
| Caldwell, JH | 1 |
| Brunswick, D | 1 |
| Conn, JW | 1 |
| Petrie, WM | 1 |
| Aronoff, GM | 1 |
| Evans, WO | 1 |
| Nasrallah, HA | 1 |
| Lyskowksi, J | 1 |
| Schroeder, D | 1 |
| Roth, T | 1 |
| Zorick, F | 1 |
| Wittig, R | 1 |
| McLenaghan, A | 1 |
| Roehrs, T | 1 |
| Steuer, J | 1 |
| Gerner, R | 2 |
| Titievsky, J | 1 |
| Seco, G | 1 |
| Barranco, M | 1 |
| Kyle, EM | 1 |
| Linnoila, M | 2 |
| Jobson, KO | 1 |
| Gilliam, JH | 1 |
| Paine, RL | 1 |
| Finnerty, RJ | 1 |
| Goldberg, HL | 1 |
| Seppala, T | 1 |
| Mattila, MJ | 1 |
| Vihko, R | 1 |
| Pakarinen, A | 1 |
| Skinner, T | 1 |
| Lingjaerde, O | 1 |
| Jørgensen, J | 1 |
| Støren, R | 1 |
| Thomle, S | 1 |
| Wendt Raeder, L | 1 |
| Ruud, LE | 1 |
| Schetelig, E | 1 |
| Sveaas, HK | 1 |
| Leivestad, O | 1 |
| Albus, M | 3 |
| Scheibe, G | 3 |
| Scherer, J | 2 |
| Nair, NP | 1 |
| Amin, M | 1 |
| Schwartz, G | 1 |
| Dastoor, D | 1 |
| Thavundayil, JX | 1 |
| Mirmiran, J | 1 |
| MacDonald, C | 1 |
| Phillips, R | 3 |
| Rechlin, T | 1 |
| Beneke, M | 1 |
| Rasmus, W | 1 |
| Rød, IS | 1 |
| Fritze, J | 1 |
| Ferguson, JM | 1 |
| Mendels, J | 1 |
| Manowitz, NR | 1 |
| König, W | 2 |
| Heinrich, T | 1 |
| Diehl, B | 1 |
| Curran, S | 1 |
| Cheung, P | 1 |
| Philipp, M | 3 |
| Kohnen, R | 1 |
| Benkert, O | 1 |
| Deister, A | 1 |
| Staberock, U | 1 |
| Höflich, G | 1 |
| Möller, HJ | 1 |
| Marttila, M | 1 |
| Jääskeläinen, J | 1 |
| Järvi, R | 1 |
| Romanov, M | 1 |
| Miettinen, E | 1 |
| Sorri, P | 1 |
| Ahlfors, U | 1 |
| Zivkov, M | 1 |
| Baker, B | 3 |
| Dorian, P | 3 |
| Sandor, P | 3 |
| Shapiro, C | 2 |
| Schell, C | 1 |
| Mitchell, J | 1 |
| Irvine, MJ | 1 |
| Hrdina, PD | 4 |
| Bakish, D | 4 |
| Ravindran, A | 1 |
| Chudzik, J | 1 |
| Cavazzoni, P | 1 |
| Lapierre, YD | 4 |
| Adler, L | 1 |
| Hajak, G | 1 |
| Lehmann, K | 1 |
| Kunert, HJ | 1 |
| Hoffmann, G | 1 |
| Issinger, J | 1 |
| Böke, J | 1 |
| Huether, G | 1 |
| Rüther, E | 2 |
| Deuschle, M | 2 |
| Schmider, J | 1 |
| Weber, B | 1 |
| Standhardt, H | 2 |
| Körner, A | 1 |
| Lammers, CH | 1 |
| Schweiger, U | 1 |
| Hartmann, A | 1 |
| Heuser, I | 2 |
| Khaykin, Y | 1 |
| Mironov, D | 1 |
| Irvine, J | 2 |
| Newman, D | 1 |
| McKessok, D | 1 |
| Mendlowitz, S | 1 |
| Nuijten, MJ | 1 |
| Hardens, M | 1 |
| Souêtre, E | 1 |
| Slomski, AJ | 1 |
| Koskentausta, T | 1 |
| Sobanski, E | 1 |
| Schmidt, MH | 1 |
| Gorelick, DA | 1 |
| Leucht, S | 1 |
| Steimer, W | 1 |
| Kreuz, S | 1 |
| Abraham, D | 1 |
| Orsulak, PJ | 1 |
| Kissling, W | 1 |
| Barańczyk-Kuźma, A | 1 |
| Sawicki, J | 1 |
| Kuźma, M | 1 |
| Jagiełło, J | 1 |
| Dunner, DL | 1 |
| Cohn, JB | 2 |
| Walshe, T | 1 |
| Cohn, CK | 1 |
| Fieve, RR | 1 |
| Halikas, JP | 1 |
| Hartford, JT | 1 |
| Hearst, ED | 1 |
| Settle, EC | 1 |
| Shafey, H | 1 |
| Leinonen, E | 1 |
| Lillsunde, P | 1 |
| Laukkanen, V | 1 |
| Ylitalo, P | 1 |
| Roose, SP | 2 |
| Dalack, GW | 2 |
| Glassman, AH | 2 |
| Woodring, S | 1 |
| Walsh, BT | 1 |
| Giardina, EG | 1 |
| Swenson, S | 2 |
| Deptula, D | 1 |
| Pomara, N | 1 |
| Lazarus, A | 1 |
| Meador-Woodruff, JH | 1 |
| Majchrzak, MJ | 1 |
| Lesch, KP | 1 |
| Stein, A | 1 |
| Gosselin, C | 1 |
| Ancill, RJ | 1 |
| Sachdev, PS | 1 |
| Small, GW | 1 |
| Assalian, P | 2 |
| Rosengarten, MD | 2 |
| Churchill, CM | 1 |
| Pariser, SF | 1 |
| Larson, CN | 1 |
| Tamminen, TT | 1 |
| Lehtinen, VV | 1 |
| Smith, WT | 1 |
| Wolf, B | 1 |
| Conradty, M | 1 |
| Grohmann, R | 1 |
| Witzgall, H | 1 |
| Londong, V | 1 |
| Feighner, J | 1 |
| Hendrickson, G | 1 |
| Miller, L | 1 |
| Stern, W | 1 |
| el-Yazigi, A | 1 |
| Chaleby, K | 1 |
| Horn, E | 1 |
| Browne, M | 1 |
| Maier, W | 2 |
| Pohl, R | 1 |
| Yeragani, VK | 1 |
| Balon, R | 1 |
| Lycaki, H | 1 |
| Marshall, ZT | 1 |
| Lippmann, SB | 1 |
| Lee, HK | 1 |
| Geeze, DS | 1 |
| Wise, MG | 1 |
| Stigelman, WH | 1 |
| Tollison, CD | 1 |
| Kriegel, ML | 1 |
| Lieff, S | 1 |
| Herrmann, N | 1 |
| Light, RW | 1 |
| Merrill, EJ | 1 |
| Despars, J | 1 |
| Gordon, GH | 1 |
| Mutalipassi, LR | 1 |
| Lodge, GJ | 1 |
| Freeman, HL | 1 |
| True, BL | 1 |
| Perry, PJ | 1 |
| Burns, EA | 1 |
| Biedermann, HJ | 1 |
| Lapeer, GL | 1 |
| Mauri, M | 1 |
| McGhie, A | 1 |
| Lennhoff, M | 1 |
| Lakshmanan, M | 1 |
| Mion, LC | 1 |
| Frengley, JD | 1 |
| Callies, AL | 1 |
| Popkin, MK | 1 |
| Harris, SJ | 1 |
| Parent, M | 1 |
| Lyons, JS | 1 |
| Rosen, AJ | 1 |
| Dysken, MW | 1 |
| Joseph, J | 1 |
| Linde, S | 1 |
| Aldrich, J | 1 |
| Conolly, ME | 1 |
| Rosen, R | 1 |
| Hill, M | 1 |
| Kemp, J | 1 |
| Ilett, KF | 1 |
| Booth, J | 1 |
| Hackett, LP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study of Antidepressants in Parkinson's Disease[NCT00086190] | Phase 3 | 115 participants (Actual) | Interventional | 2005-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Beck Depression Inventory II ranges from 0-63. Higher score indicates more severe depression. 0-13 minimal depression, 14-19 mild depression, 20-28 moderate depression, 29-63 severe depression. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in BDI-II score (Mean) |
|---|---|
| Paroxetine | -9.7 |
| Venlafaxine Extended Release | -9.6 |
| Placebo | -5.2 |
Brief Psychiatric Rating Scale. Maximum score 126. Higher score indicates greater psychiatric difficulties. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in BPRS score (Mean) |
|---|---|
| Paroxetine | -9.0 |
| Venlafaxine Extended Release | -9.8 |
| Placebo | -4.4 |
Geriatric Depression Scale ranges from 0-30. Higher score indicates more severe depression. 0-9 normal, 10-19 mild depression, 20-30 severe depression. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in GDS score (Mean) |
|---|---|
| Paroxetine | -6.9 |
| Venlafaxine Extended Release | -6.9 |
| Placebo | -2.8 |
Change in Hamilton Rating Scale for Depression over 12 weeks. Hamilton Depression Rating Scale ranges from 0-50. Higher scores represent more significant depression. Mild depression ranges from 8-13, moderate depression from 14-18, severe 19-22 and very severe any score over 23. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in HAM-D score (Mean) |
|---|---|
| Paroxetine | -13.0 |
| Venlafaxine Extended Release | -11.0 |
| Placebo | -6.8 |
Montgomery-Asberg Depression Rating Scale ranges from 0-60. Higher score indicates more severe depression. 0-6 normal, 7-19 mild depression, 20-34 moderate depression, greater than 34 severe depression. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in MADRS score (Mean) |
|---|---|
| Paroxetine | -13.6 |
| Venlafaxine Extended Release | -10.9 |
| Placebo | -6.6 |
Parkinson's Disease Questionnaire (PDQ-39) - Emotional Well-Being maximum score 24, minimum score of 0.Lower score indicates a better perceived health status. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in PDQ-39 Emotional score (Mean) |
|---|---|
| Paroxetine | -21.4 |
| Venlafaxine Extended Release | -20.7 |
| Placebo | -10.9 |
Parkinson's Disease Questionnaire (PDQ-39) Total. Range 0-100. Lower score indicates a better perceived health status. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in PDQ-39 score (Mean) |
|---|---|
| Paroxetine | -8.0 |
| Venlafaxine Extended Release | -8.4 |
| Placebo | -5.3 |
Pittsburgh Sleep Quality Index scores range from 0-21, with higher scores indicating severe sleep difficulties. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in PQSI score (Mean) |
|---|---|
| Paroxetine | -2.1 |
| Venlafaxine Extended Release | -2.6 |
| Placebo | -1.1 |
Short Form 36 Health Survey. Range 0-100. Higher score indicates a better perceived quality of life. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in SF-36 mental score (Mean) |
|---|---|
| Paroxetine | 11.4 |
| Venlafaxine Extended Release | 9.5 |
| Placebo | 4.8 |
Short Form 36 Health Survey - Mental Health subscale ranges from 0-100. Higher score indicates a better perceived quality of life. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in SF-36 Mental Health score (Mean) |
|---|---|
| Paroxetine | 16.7 |
| Venlafaxine Extended Release | 17.4 |
| Placebo | 9.7 |
Short Form 36 Health Survey - Emotional subscale ranges from 0-100. Higher score indicates a better perceived quality of life. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in SF-36 Role score (Mean) |
|---|---|
| Paroxetine | 39.5 |
| Venlafaxine Extended Release | 26.9 |
| Placebo | 12.7 |
Short Form 36 Health Survey - Vitality subscale ranges from 0-100. Higher score indicates a better perceived quality of life. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in SF-36 vitality score (Mean) |
|---|---|
| Paroxetine | 13.5 |
| Venlafaxine Extended Release | 9.1 |
| Placebo | 4.7 |
Snaith Clinical Anxiety Scale. Range 0-21. Higher scores indicate increased anxiety. Score greater than 8 indicates clinical anxiety. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in CAS score (Mean) |
|---|---|
| Paroxetine | -3.6 |
| Venlafaxine Extended Release | -3.2 |
| Placebo | -2.4 |
Unified Parkinson's Disease Rating Scale. Higher score indicates more severe Parkinson's disease symptoms. Total maximum = 176. Mental maximum = 52, Activities of Daily Living maximum = 52, Motor maximum = 72. Minimum = 0. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in UPDRS score (Mean) |
|---|---|
| Paroxetine | -8.7 |
| Venlafaxine Extended Release | -7.0 |
| Placebo | -4.3 |
Unified Parkinson's Disease Rating Scale - Bulbar maximum score 24, minimum score of 0. Higher score indicates more severe Parkinson's disease symptoms. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in UPDRS-Bulbar score (Mean) |
|---|---|
| Paroxetine | -1.4 |
| Venlafaxine Extended Release | -1.4 |
| Placebo | -0.5 |
Unified Parkinson's Disease Rating Scale - Motor has a maximum score of 72, minimum score of 0. Higher score indicates more severe Parkinson's disease symptoms. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in UPDRS-motor score (Mean) |
|---|---|
| Paroxetine | -4.3 |
| Venlafaxine Extended Release | -2.0 |
| Placebo | -1.0 |
Unified Parkinson's Disease Rating Scale - Tremor subscale ranges from 0-23. Higher score indicates more severe Parkinson's disease symptoms. (NCT00086190)
Timeframe: from the beginning (0 weeks) to end (12 weeks) of the double-blind phase
| Intervention | Change in UPDRS-tremor score (Mean) |
|---|---|
| Paroxetine | 0.4 |
| Venlafaxine Extended Release | 0.5 |
| Placebo | -0.6 |
6 reviews available for doxepin and Depressive Disorder
| Article | Year |
|---|---|
Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation.
Topics: Antidepressive Agents; Bupropion; Controlled Clinical Trials as Topic; Depressive Disorder; Doxepin; | 2003 |
Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation.
Topics: Antidepressive Agents; Bupropion; Controlled Clinical Trials as Topic; Depressive Disorder; Doxepin; | 2003 |
Review of clinical and animal studies comparing the cardiovascular effects of doxepin and other tricyclic antidepressants.
Topics: Animals; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Blood Pressure; Cardiovascular Syst | 1983 |
Review of clinical and animal studies comparing the cardiovascular effects of doxepin and other tricyclic antidepressants.
Topics: Animals; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Blood Pressure; Cardiovascular Syst | 1983 |
Doxepin as an adjunct in the treatment of chronic pain.
Topics: Chronic Disease; Clinical Trials as Topic; Depression; Depressive Disorder; Doxepin; Humans; Hydroxy | 1982 |
Doxepin as an adjunct in the treatment of chronic pain.
Topics: Chronic Disease; Clinical Trials as Topic; Depression; Depressive Disorder; Doxepin; Humans; Hydroxy | 1982 |
Effects of antidepressants on human performance: a review.
Topics: Age Factors; Amitriptyline; Antidepressive Agents; Depressive Disorder; Doxepin; Humans; Imipramine; | 1990 |
Effects of antidepressants on human performance: a review.
Topics: Age Factors; Amitriptyline; Antidepressive Agents; Depressive Disorder; Doxepin; Humans; Imipramine; | 1990 |
Tricyclic antidepressants for medically ill geriatric patients.
Topics: Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Desipramine; Doxepin; Geriatrics; Human | 1989 |
Tricyclic antidepressants for medically ill geriatric patients.
Topics: Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Desipramine; Doxepin; Geriatrics; Human | 1989 |
Steady-state kinetics of doxepin and imipramine in Saudi patients with interethnic comparison.
Topics: Adolescent; Adult; Depressive Disorder; Doxepin; Europe; Female; Humans; Imipramine; Male; Middle Ag | 1988 |
Steady-state kinetics of doxepin and imipramine in Saudi patients with interethnic comparison.
Topics: Adolescent; Adult; Depressive Disorder; Doxepin; Europe; Female; Humans; Imipramine; Male; Middle Ag | 1988 |
59 trials available for doxepin and Depressive Disorder
| Article | Year |
|---|---|
Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Doxepin; Drug Monitoring; Fema | 2003 |
Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions?
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Doxepin; Drug Monitoring; Fema | 2003 |
Motor cortex excitability after vagus nerve stimulation in major depression.
Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Ther | 2007 |
Motor cortex excitability after vagus nerve stimulation in major depression.
Topics: Adult; Benzodiazepines; Citalopram; Clomipramine; Clozapine; Depressive Disorder; Doxepin; Drug Ther | 2007 |
A randomized controlled clinical trial comparing "guideline exposed" and "guideline naive" physicians in respect to dosage selection and treatment outcome with doxepin in depressive disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Depressive Disorder; D | 2007 |
A randomized controlled clinical trial comparing "guideline exposed" and "guideline naive" physicians in respect to dosage selection and treatment outcome with doxepin in depressive disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Depressive Disorder; D | 2007 |
The role of chemotherapy in managing potentially suicidal patients.
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Crisis Intervention; Depressive | 1974 |
The role of chemotherapy in managing potentially suicidal patients.
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Crisis Intervention; Depressive | 1974 |
Benzodiazepines as antidepressants. A triazolobenzodiazepine used to treat depression.
Topics: Alprazolam; Amitriptyline; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Depressiv | 1982 |
Benzodiazepines as antidepressants. A triazolobenzodiazepine used to treat depression.
Topics: Alprazolam; Amitriptyline; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Depressiv | 1982 |
Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; | 1984 |
Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; | 1984 |
Comparative cardiac effects of maprotiline and doxepin in elderly depressed patients.
Topics: Aged; Angina Pectoris; Anthracenes; Blood Pressure; Cardiac Complexes, Premature; Clinical Trials as | 1984 |
Comparative cardiac effects of maprotiline and doxepin in elderly depressed patients.
Topics: Aged; Angina Pectoris; Anthracenes; Blood Pressure; Cardiac Complexes, Premature; Clinical Trials as | 1984 |
Doxepin's effects on chronic pain and depression: a controlled study.
Topics: beta-Endorphin; Chronic Disease; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; | 1984 |
Doxepin's effects on chronic pain and depression: a controlled study.
Topics: beta-Endorphin; Chronic Disease; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; | 1984 |
Antidepressants in concomitant chronic back pain and depression: doxepin and desipramine compared.
Topics: Adult; Anxiety Disorders; Back Pain; beta-Endorphin; Chronic Disease; Clinical Trials as Topic; Depr | 1984 |
Antidepressants in concomitant chronic back pain and depression: doxepin and desipramine compared.
Topics: Adult; Anxiety Disorders; Back Pain; beta-Endorphin; Chronic Disease; Clinical Trials as Topic; Depr | 1984 |
Pretreatment orthostatic hypotension in geriatric depression: predictor of response to imipramine and doxepin.
Topics: Aged; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Doxepin; Female; Humans; H | 1983 |
Pretreatment orthostatic hypotension in geriatric depression: predictor of response to imipramine and doxepin.
Topics: Aged; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Doxepin; Female; Humans; H | 1983 |
Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
Topics: Anthracenes; Clinical Trials as Topic; Constipation; Depressive Disorder; Dizziness; Double-Blind Me | 1983 |
Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
Topics: Anthracenes; Clinical Trials as Topic; Constipation; Depressive Disorder; Dizziness; Double-Blind Me | 1983 |
Long-term treatment of chronic depression: 15-year experience with doxepin HCl.
Topics: Adult; Aged; Ambulatory Care; Chronic Disease; Clinical Trials as Topic; Depressive Disorder; Doxepi | 1984 |
Long-term treatment of chronic depression: 15-year experience with doxepin HCl.
Topics: Adult; Aged; Ambulatory Care; Chronic Disease; Clinical Trials as Topic; Depressive Disorder; Doxepi | 1984 |
A comparison of clomipramine and doxepin in neurotic depression.
Topics: Adolescent; Adult; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; | 1984 |
A comparison of clomipramine and doxepin in neurotic depression.
Topics: Adolescent; Adult; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; | 1984 |
Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive D | 1983 |
Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive D | 1983 |
Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.
Topics: Adult; Ambulatory Care; Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Double-Blind M | 1982 |
Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.
Topics: Adult; Ambulatory Care; Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Double-Blind M | 1982 |
Mianserin and doxepin in the treatment of outpatient depression with anxiety.
Topics: Adult; Aged; Anxiety Disorders; Depressive Disorder; Dibenzazepines; Doxepin; Electrocardiography; F | 1983 |
Mianserin and doxepin in the treatment of outpatient depression with anxiety.
Topics: Adult; Aged; Anxiety Disorders; Depressive Disorder; Dibenzazepines; Doxepin; Electrocardiography; F | 1983 |
Doxepin and hydroxyzine in treating anxiety: effects of failure and motivation on cognitive performance.
Topics: Adult; Anxiety Disorders; Cognition; Depressive Disorder; Doxepin; Humans; Hydroxyzine; Male; Middle | 1983 |
Doxepin and hydroxyzine in treating anxiety: effects of failure and motivation on cognitive performance.
Topics: Adult; Anxiety Disorders; Cognition; Depressive Disorder; Doxepin; Humans; Hydroxyzine; Male; Middle | 1983 |
Onset of action of amoxapine and doxepin in outpatients with "mixed anxiety/depression".
Topics: Adult; Ambulatory Care; Amoxapine; Anxiety Disorders; Constipation; Depressive Disorder; Dibenzoxaze | 1983 |
Onset of action of amoxapine and doxepin in outpatients with "mixed anxiety/depression".
Topics: Adult; Ambulatory Care; Amoxapine; Anxiety Disorders; Constipation; Depressive Disorder; Dibenzoxaze | 1983 |
Stimulus intensity control in depression: a study of the comparative effect of doxepin and amitriptyline on cortical evoked potentials.
Topics: Adolescent; Adult; Aged; Amitriptyline; Auditory Perception; Depressive Disorder; Doxepin; Electroen | 1980 |
Stimulus intensity control in depression: a study of the comparative effect of doxepin and amitriptyline on cortical evoked potentials.
Topics: Adolescent; Adult; Aged; Amitriptyline; Auditory Perception; Depressive Disorder; Doxepin; Electroen | 1980 |
Viloxazine in the treatment of depressive neurosis: a controlled clinical study with doxepin and placebo.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Doxepin; Female; Humans; | 1980 |
Viloxazine in the treatment of depressive neurosis: a controlled clinical study with doxepin and placebo.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Doxepin; Female; Humans; | 1980 |
Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Blood Pressure; Chronic Disease | 1982 |
Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Blood Pressure; Chronic Disease | 1982 |
Double-blind comparison of doxepin and desipramine in patients with primary affective disorder.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Depressive Disorder; Desipramine; Double-Blin | 1982 |
Double-blind comparison of doxepin and desipramine in patients with primary affective disorder.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Depressive Disorder; Desipramine; Double-Blin | 1982 |
A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives.
Topics: Adolescent; Adult; Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Dizziness; Doxepin; | 1982 |
A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives.
Topics: Adolescent; Adult; Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Dizziness; Doxepin; | 1982 |
Doxepin as an adjunct in the treatment of chronic pain.
Topics: Chronic Disease; Clinical Trials as Topic; Depression; Depressive Disorder; Doxepin; Humans; Hydroxy | 1982 |
Doxepin as an adjunct in the treatment of chronic pain.
Topics: Chronic Disease; Clinical Trials as Topic; Depression; Depressive Disorder; Doxepin; Humans; Hydroxy | 1982 |
Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study.
Topics: Adult; Depressive Disorder; Double-Blind Method; Doxepin; Drug Therapy, Combination; Female; Humans; | 1982 |
Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study.
Topics: Adult; Depressive Disorder; Double-Blind Method; Doxepin; Drug Therapy, Combination; Female; Humans; | 1982 |
Specific responses to imipramine and doxepin in psychoneurotic depressed patients with sleep disturbance.
Topics: Adult; Depressive Disorder; Double-Blind Method; Doxepin; Female; Humans; Imipramine; Male; Random A | 1981 |
Specific responses to imipramine and doxepin in psychoneurotic depressed patients with sleep disturbance.
Topics: Adult; Depressive Disorder; Double-Blind Method; Doxepin; Female; Humans; Imipramine; Male; Random A | 1981 |
Clomipramine and doxepin in depressive neurosis. Plasma levels and therapeutic response.
Topics: Adult; Clomipramine; Depressive Disorder; Doxepin; Female; Humans; Male; Reaction Time; Tryptophan | 1980 |
Clomipramine and doxepin in depressive neurosis. Plasma levels and therapeutic response.
Topics: Adult; Clomipramine; Depressive Disorder; Doxepin; Female; Humans; Male; Reaction Time; Tryptophan | 1980 |
A double-blind comparison of moclobemide and doxepin in depressed general practice patients.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Depressive Disorder; Dose-Respo | 1995 |
A double-blind comparison of moclobemide and doxepin in depressed general practice patients.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzamides; Depressive Disorder; Dose-Respo | 1995 |
Panic disorder with or without concomitant depression 5 years after treatment: a prospective follow-up.
Topics: Adult; Agoraphobia; Combined Modality Therapy; Comorbidity; Depressive Disorder; Doxepin; Female; Fo | 1995 |
Panic disorder with or without concomitant depression 5 years after treatment: a prospective follow-up.
Topics: Adult; Agoraphobia; Combined Modality Therapy; Comorbidity; Depressive Disorder; Doxepin; Female; Fo | 1995 |
A comparison of the cardiac safety and therapeutic efficacy of trimipramine versus doxepin in geriatric depressed patients.
Topics: Age Factors; Aged; Analysis of Variance; Blood Pressure; Cardiac Complexes, Premature; Cognition; De | 1993 |
A comparison of the cardiac safety and therapeutic efficacy of trimipramine versus doxepin in geriatric depressed patients.
Topics: Age Factors; Aged; Analysis of Variance; Blood Pressure; Cardiac Complexes, Premature; Cognition; De | 1993 |
The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability.
Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Dose-Response Relationship, Drug; Doxepin; Drug Adm | 1994 |
The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability.
Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Dose-Response Relationship, Drug; Doxepin; Drug Adm | 1994 |
Dothiepin versus doxepin in major depression: results of a multicenter, placebo-controlled trial. Prothiaden Collaborative Study Group.
Topics: Adult; Aged; Ambulatory Care; Depressive Disorder; Dothiepin; Double-Blind Method; Doxepin; Drug Adm | 1994 |
Dothiepin versus doxepin in major depression: results of a multicenter, placebo-controlled trial. Prothiaden Collaborative Study Group.
Topics: Adult; Aged; Ambulatory Care; Depressive Disorder; Dothiepin; Double-Blind Method; Doxepin; Drug Adm | 1994 |
A double-blind comparison of amitriptylinoxide versus doxepine in the treatment of severe depression.
Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Double-Blind Method; Doxepin; Female; Humans; Male; | 1994 |
A double-blind comparison of amitriptylinoxide versus doxepine in the treatment of severe depression.
Topics: Adult; Aged; Amitriptyline; Depressive Disorder; Double-Blind Method; Doxepin; Female; Humans; Male; | 1994 |
Outcome of panic disorder with or without concomitant depression: A 2-year prospective follow-up study.
Topics: Adult; Ambulatory Care; Antidepressive Agents; Combined Modality Therapy; Comorbidity; Depressive Di | 1993 |
Outcome of panic disorder with or without concomitant depression: A 2-year prospective follow-up study.
Topics: Adult; Ambulatory Care; Antidepressive Agents; Combined Modality Therapy; Comorbidity; Depressive Di | 1993 |
A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction.
Topics: Adult; Benzamides; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Doxep | 1993 |
A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction.
Topics: Adult; Benzamides; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Doxep | 1993 |
Fluctuation of symptoms and social functioning in panic disorder with or without concomitant depression. A 5-year prospective follow-up.
Topics: Agoraphobia; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Doxepin; Follow-Up | 1995 |
Fluctuation of symptoms and social functioning in panic disorder with or without concomitant depression. A 5-year prospective follow-up.
Topics: Agoraphobia; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Doxepin; Follow-Up | 1995 |
Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse.
Topics: Adult; Aged; Aged, 80 and over; Aging; Amitriptyline; Antidepressive Agents, Tricyclic; Body Mass In | 1996 |
Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse.
Topics: Adult; Aged; Aged, 80 and over; Aging; Amitriptyline; Antidepressive Agents, Tricyclic; Body Mass In | 1996 |
A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Doxep | 1995 |
A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression.
Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Doxep | 1995 |
Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disord | 1997 |
Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disord | 1997 |
On the problems of switching from intravenous to oral administration in drug treatment of endogenous depression--a placebo-controlled double-blind trial with doxepin.
Topics: Administration, Oral; Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Met | 1997 |
On the problems of switching from intravenous to oral administration in drug treatment of endogenous depression--a placebo-controlled double-blind trial with doxepin.
Topics: Administration, Oral; Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Met | 1997 |
Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Dexamethasone; Double-Blind Method; Do | 1997 |
Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Dexamethasone; Double-Blind Method; Do | 1997 |
Doxepin and its metabolites in plasma and cerebrospinal fluid in depressed patients.
Topics: Adult; Cerebrospinal Fluid; Depressive Disorder; Doxepin; Female; Humans; Male; Middle Aged | 1997 |
Doxepin and its metabolites in plasma and cerebrospinal fluid in depressed patients.
Topics: Adult; Cerebrospinal Fluid; Depressive Disorder; Doxepin; Female; Humans; Male; Middle Aged | 1997 |
Autonomic correlates of antidepressant treatment using heart-rate variability analysis.
Topics: Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Au | 1998 |
Autonomic correlates of antidepressant treatment using heart-rate variability analysis.
Topics: Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Au | 1998 |
Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disord | 1998 |
Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disord | 1998 |
Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
Topics: Age Factors; Aged; Ambulatory Care; Antidepressive Agents; Depressive Disorder; Double-Blind Method; | 1992 |
Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
Topics: Age Factors; Aged; Ambulatory Care; Antidepressive Agents; Depressive Disorder; Double-Blind Method; | 1992 |
[Intravenous versus oral treatment of endogenously depressed patients with doxepin--a double-blind study with plasma level determination].
Topics: Administration, Oral; Adult; Aged; Depressive Disorder; Double-Blind Method; Doxepin; Female; Humans | 1989 |
[Intravenous versus oral treatment of endogenously depressed patients with doxepin--a double-blind study with plasma level determination].
Topics: Administration, Oral; Adult; Aged; Depressive Disorder; Double-Blind Method; Doxepin; Female; Humans | 1989 |
Comparative trial of trimipramine versus doxepin in depressed hospitalised patients.
Topics: Clinical Trials as Topic; Depressive Disorder; Dibenzazepines; Double-Blind Method; Doxepin; Female; | 1989 |
Comparative trial of trimipramine versus doxepin in depressed hospitalised patients.
Topics: Clinical Trials as Topic; Depressive Disorder; Dibenzazepines; Double-Blind Method; Doxepin; Female; | 1989 |
A double-blind parallel study to compare fluoxetine with doxepin in the treatment of major depressive disorders.
Topics: Adult; Depressive Disorder; Double-Blind Method; Doxepin; Female; Fluoxetine; Humans; Male; Middle A | 1989 |
A double-blind parallel study to compare fluoxetine with doxepin in the treatment of major depressive disorders.
Topics: Adult; Depressive Disorder; Double-Blind Method; Doxepin; Female; Fluoxetine; Humans; Male; Middle A | 1989 |
A comparative trial of the antidepressant, anxiolytic, and cardiovascular effects of trimipramine and doxepin in depressed hospitalized patients.
Topics: Anorexia; Anti-Anxiety Agents; Clinical Trials as Topic; Depressive Disorder; Dibenzazepines; Dizzin | 1985 |
A comparative trial of the antidepressant, anxiolytic, and cardiovascular effects of trimipramine and doxepin in depressed hospitalized patients.
Topics: Anorexia; Anti-Anxiety Agents; Clinical Trials as Topic; Depressive Disorder; Dibenzazepines; Dizzin | 1985 |
Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression.
Topics: Adult; Alcoholism; Alprazolam; Ambulatory Care; Amitriptyline; Anti-Anxiety Agents; Benzodiazepines; | 1985 |
Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression.
Topics: Adult; Alcoholism; Alprazolam; Ambulatory Care; Amitriptyline; Anti-Anxiety Agents; Benzodiazepines; | 1985 |
Tricyclic antidepressants for chronic low-back pain. Mechanisms of action and predictors of response.
Topics: Adult; Back Pain; Chronic Disease; Clinical Trials as Topic; Depressive Disorder; Desipramine; Doubl | 1986 |
Tricyclic antidepressants for chronic low-back pain. Mechanisms of action and predictors of response.
Topics: Adult; Back Pain; Chronic Disease; Clinical Trials as Topic; Depressive Disorder; Desipramine; Doubl | 1986 |
Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder.
Topics: Adult; Aged; Antidepressive Agents; Body Weight; Bupropion; Clinical Trials as Topic; Depressive Dis | 1986 |
Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder.
Topics: Adult; Aged; Antidepressive Agents; Body Weight; Bupropion; Clinical Trials as Topic; Depressive Dis | 1986 |
Antidepressant plasma levels and clinical response in depressed patients treated with oxaprotiline and doxepin.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Doxepin; Female; Humans; Male; Maprotiline; Middl | 1988 |
Antidepressant plasma levels and clinical response in depressed patients treated with oxaprotiline and doxepin.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Doxepin; Female; Humans; Male; Maprotiline; Middl | 1988 |
Doxepin treatment of depressed patients with chronic obstructive pulmonary disease.
Topics: Aged; Anxiety; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Doxepin; Emotions | 1986 |
Doxepin treatment of depressed patients with chronic obstructive pulmonary disease.
Topics: Aged; Anxiety; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Doxepin; Emotions | 1986 |
Clovoxamine and doxepin in major depressive disorder: a double-blind controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Blood Pressure; Body Weight; Clinical Trials as Topi | 1986 |
Clovoxamine and doxepin in major depressive disorder: a double-blind controlled trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Blood Pressure; Body Weight; Clinical Trials as Topi | 1986 |
Effective low dose tricyclic antidepressant treatment for depressed geriatric rehabilitation patients. A double-blind study.
Topics: Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Doxepin; Female; H | 1986 |
Effective low dose tricyclic antidepressant treatment for depressed geriatric rehabilitation patients. A double-blind study.
Topics: Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Doxepin; Female; H | 1986 |
Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder.
Topics: Age Factors; Aged; Anxiety; Blood Pressure; Body Weight; Clinical Trials as Topic; Depressive Disord | 1985 |
Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder.
Topics: Age Factors; Aged; Anxiety; Blood Pressure; Body Weight; Clinical Trials as Topic; Depressive Disord | 1985 |
Behavioral effects of tricyclic drugs in depressed inpatients.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Doxepin; Female; Humans | 1985 |
Behavioral effects of tricyclic drugs in depressed inpatients.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Doxepin; Female; Humans | 1985 |
Orthostatic effect of imipramine and doxepin in depressed geriatric outpatients.
Topics: Age Factors; Aged; Depressive Disorder; Double-Blind Method; Doxepin; Female; Humans; Hypotension, O | 1985 |
Orthostatic effect of imipramine and doxepin in depressed geriatric outpatients.
Topics: Age Factors; Aged; Depressive Disorder; Double-Blind Method; Doxepin; Female; Humans; Hypotension, O | 1985 |
60 other studies available for doxepin and Depressive Disorder
| Article | Year |
|---|---|
Doxepin-Associated Hypoglycemia in an Ambulatory Nondiabetic Patient.
Topics: Depressive Disorder; Doxepin; Humans; Hypoglycemia | 2023 |
Doxepin-Associated Hypoglycemia in an Ambulatory Nondiabetic Patient.
Topics: Depressive Disorder; Doxepin; Humans; Hypoglycemia | 2023 |
Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depre | 2017 |
Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depre | 2017 |
Doxepin concentrations in plasma and cerebrospinal fluid.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Doxepin; Female; Humans; Male; M | 2011 |
Doxepin concentrations in plasma and cerebrospinal fluid.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Doxepin; Female; Humans; Male; M | 2011 |
Psychobiological markers in coexisting pain and depression: toward a unified theory.
Topics: Anxiety Disorders; Brain; Depressive Disorder; Doxepin; Humans; Hydroxyindoleacetic Acid; Methoxyhyd | 1982 |
Psychobiological markers in coexisting pain and depression: toward a unified theory.
Topics: Anxiety Disorders; Brain; Depressive Disorder; Doxepin; Humans; Hydroxyindoleacetic Acid; Methoxyhyd | 1982 |
Anxiety in depression.
Topics: Adult; Anxiety Disorders; Combined Modality Therapy; Depressive Disorder; Dose-Response Relationship | 1984 |
Anxiety in depression.
Topics: Adult; Anxiety Disorders; Combined Modality Therapy; Depressive Disorder; Dose-Response Relationship | 1984 |
Doxepin and tinnitus.
Topics: Aged; Depressive Disorder; Doxepin; Female; Humans; Tinnitus | 1983 |
Doxepin and tinnitus.
Topics: Aged; Depressive Disorder; Doxepin; Female; Humans; Tinnitus | 1983 |
Multiple-dose doxepin kinetics in depressed patients.
Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Doxepin; Humans; Kinetics; Male; Middl | 1983 |
Multiple-dose doxepin kinetics in depressed patients.
Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Doxepin; Humans; Kinetics; Male; Middl | 1983 |
Ventricular arrhythmias induced by doxepin and amitriptyline: case report.
Topics: Amitriptyline; Arrhythmias, Cardiac; Depressive Disorder; Doxepin; Humans; Male; Middle Aged | 1983 |
Ventricular arrhythmias induced by doxepin and amitriptyline: case report.
Topics: Amitriptyline; Arrhythmias, Cardiac; Depressive Disorder; Doxepin; Humans; Male; Middle Aged | 1983 |
Doxepin's cardiotoxicity reviewed.
Topics: Animals; Anxiety Disorders; Cardiovascular Diseases; Depressive Disorder; Doxepin; Humans; Research | 1984 |
Doxepin's cardiotoxicity reviewed.
Topics: Animals; Anxiety Disorders; Cardiovascular Diseases; Depressive Disorder; Doxepin; Humans; Research | 1984 |
The dexamethasone suppression test in depressive illness: clinical correlates.
Topics: Depressive Disorder; Desipramine; Dexamethasone; Diagnosis, Differential; Double-Blind Method; Doxep | 1982 |
The dexamethasone suppression test in depressive illness: clinical correlates.
Topics: Depressive Disorder; Desipramine; Dexamethasone; Diagnosis, Differential; Double-Blind Method; Doxep | 1982 |
Urinary 3-methoxy-4-hydroxyphenethylene glycol in the prediction of pain and depression relief with doxepin: preliminary findings.
Topics: Adult; Anxiety Disorders; Depressive Disorder; Doxepin; Female; Glycols; Humans; Male; Methoxyhydrox | 1983 |
Urinary 3-methoxy-4-hydroxyphenethylene glycol in the prediction of pain and depression relief with doxepin: preliminary findings.
Topics: Adult; Anxiety Disorders; Depressive Disorder; Doxepin; Female; Glycols; Humans; Male; Methoxyhydrox | 1983 |
Tricyclic antidepressants and supine, standing, and exercise plasma norepinephrine levels.
Topics: Adult; Amitriptyline; Blood Pressure; Depressive Disorder; Doxepin; Epinephrine; Female; Heart Rate; | 1983 |
Tricyclic antidepressants and supine, standing, and exercise plasma norepinephrine levels.
Topics: Adult; Amitriptyline; Blood Pressure; Depressive Disorder; Doxepin; Epinephrine; Female; Heart Rate; | 1983 |
Is amitriptyline + perphenazine superior to doxepin?
Topics: Ambulatory Care; Amitriptyline; Depressive Disorder; Doxepin; Drug Combinations; Drug Therapy, Combi | 1983 |
Is amitriptyline + perphenazine superior to doxepin?
Topics: Ambulatory Care; Amitriptyline; Depressive Disorder; Doxepin; Drug Combinations; Drug Therapy, Combi | 1983 |
Relationship between tricyclic antidepressant plasma levels and clinical response in patients treated with desipramine or doxepin.
Topics: Adult; Depressive Disorder; Desipramine; Doxepin; Female; Humans; Male; Middle Aged; Random Allocati | 1983 |
Relationship between tricyclic antidepressant plasma levels and clinical response in patients treated with desipramine or doxepin.
Topics: Adult; Depressive Disorder; Desipramine; Doxepin; Female; Humans; Male; Middle Aged; Random Allocati | 1983 |
Depression in a patient with dementia secondary to cerebrotendinous xanthomatosis.
Topics: Depressive Disorder; Doxepin; Haloperidol; Humans; Lipidoses; Male; Middle Aged; Neurocognitive Diso | 1983 |
Depression in a patient with dementia secondary to cerebrotendinous xanthomatosis.
Topics: Depressive Disorder; Doxepin; Haloperidol; Humans; Lipidoses; Male; Middle Aged; Neurocognitive Diso | 1983 |
The use of antidepressants with methadone in depressed maintenance patients.
Topics: Depressive Disorder; Doxepin; Female; Humans; Imipramine; Male; Methadone; Middle Aged; Opioid-Relat | 1982 |
The use of antidepressants with methadone in depressed maintenance patients.
Topics: Depressive Disorder; Doxepin; Female; Humans; Imipramine; Male; Methadone; Middle Aged; Opioid-Relat | 1982 |
TCA-induced mania: differences between switchers and nonswitchers.
Topics: Adult; Affective Disorders, Psychotic; Age Factors; Amitriptyline; Antidepressive Agents, Tricyclic; | 1982 |
TCA-induced mania: differences between switchers and nonswitchers.
Topics: Adult; Affective Disorders, Psychotic; Age Factors; Amitriptyline; Antidepressive Agents, Tricyclic; | 1982 |
The effects of doxepin HCl on sleep and depression.
Topics: Adult; Circadian Rhythm; Depressive Disorder; Dose-Response Relationship, Drug; Doxepin; Female; Hum | 1982 |
The effects of doxepin HCl on sleep and depression.
Topics: Adult; Circadian Rhythm; Depressive Disorder; Dose-Response Relationship, Drug; Doxepin; Female; Hum | 1982 |
Treating geriatric depression: a 26-week interim analysis.
Topics: Antidepressive Agents, Tricyclic; Behavior Therapy; Cognition; Depressive Disorder; Double-Blind Met | 1982 |
Treating geriatric depression: a 26-week interim analysis.
Topics: Antidepressive Agents, Tricyclic; Behavior Therapy; Cognition; Depressive Disorder; Double-Blind Met | 1982 |
The relationship of therapeutic response to antidepressant plasma levels: an update.
Topics: Adult; Age Factors; Aged; Amitriptyline; Antidepressive Agents; Biological Availability; Depressive | 1982 |
The relationship of therapeutic response to antidepressant plasma levels: an update.
Topics: Adult; Age Factors; Aged; Amitriptyline; Antidepressive Agents; Biological Availability; Depressive | 1982 |
Effects of doxepin on blood pressure and heart rate in patients with primary major affective disorder.
Topics: Adult; Aged; Blood Pressure; Depressive Disorder; Doxepin; Female; Heart Rate; Humans; Male; Middle | 1982 |
Effects of doxepin on blood pressure and heart rate in patients with primary major affective disorder.
Topics: Adult; Aged; Blood Pressure; Depressive Disorder; Doxepin; Female; Heart Rate; Humans; Male; Middle | 1982 |
Correct titration of non-drugs and some other methodological issues.
Topics: Administration, Oral; Amitriptyline; Anxiety Disorders; Benperidol; Depressive Disorder; Dose-Respon | 1994 |
Correct titration of non-drugs and some other methodological issues.
Topics: Administration, Oral; Amitriptyline; Anxiety Disorders; Benperidol; Depressive Disorder; Dose-Respon | 1994 |
Tricyclic-induced seizures and absent ECT response.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Doxepin; Electroconvulsive The | 1994 |
Tricyclic-induced seizures and absent ECT response.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Doxepin; Electroconvulsive The | 1994 |
Somatisation as a presentation in depression and post-traumatic stress disorder among Cambodian refugees.
Topics: Adult; Cambodia; Combined Modality Therapy; Depressive Disorder; Doxepin; Ethnicity; Female; Humans; | 1993 |
Somatisation as a presentation in depression and post-traumatic stress disorder among Cambodian refugees.
Topics: Adult; Cambodia; Combined Modality Therapy; Depressive Disorder; Doxepin; Ethnicity; Female; Humans; | 1993 |
Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Blood Platelets; Carrier Proteins; De | 1997 |
Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Blood Platelets; Carrier Proteins; De | 1997 |
[Current therapeutic possibilities with tricyclic antidepressive agents].
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder; Doxepin; Humans | 1994 |
[Current therapeutic possibilities with tricyclic antidepressive agents].
Topics: Antidepressive Agents, Tricyclic; Depressive Disorder; Doxepin; Humans | 1994 |
A Markov process analysis comparing the cost effectiveness of maintenance therapy with citalopram versus standard therapy in major depression.
Topics: Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Citalopram; Cost-Benefit Ana | 1995 |
A Markov process analysis comparing the cost effectiveness of maintenance therapy with citalopram versus standard therapy in major depression.
Topics: Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Citalopram; Cost-Benefit Ana | 1995 |
Could you be blamed for a patient's suicide?
Topics: Adult; Antidepressive Agents; Depressive Disorder; Doxepin; Drug Prescriptions; Family Practice; Fem | 1999 |
Could you be blamed for a patient's suicide?
Topics: Adult; Antidepressive Agents; Depressive Disorder; Doxepin; Drug Prescriptions; Family Practice; Fem | 1999 |
[Depression of a developmentally retarded patient].
Topics: Abnormalities, Multiple; Antidepressive Agents, Tricyclic; Depressive Disorder; Disease Progression; | 1996 |
[Depression of a developmentally retarded patient].
Topics: Abnormalities, Multiple; Antidepressive Agents, Tricyclic; Depressive Disorder; Disease Progression; | 1996 |
'Everybody looks at my pubic bone'--a case report of an adolescent patient with body dysmorphic disorder.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Comorbidity; Depressive Dis | 2000 |
'Everybody looks at my pubic bone'--a case report of an adolescent patient with body dysmorphic disorder.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Comorbidity; Depressive Dis | 2000 |
Managing depression in outpatients.
Topics: Alcoholism; Antidepressive Agents, Tricyclic; Depressive Disorder; Doxepin; Drug Approval; Humans | 2001 |
Managing depression in outpatients.
Topics: Alcoholism; Antidepressive Agents, Tricyclic; Depressive Disorder; Doxepin; Drug Approval; Humans | 2001 |
Doxepin plasma concentrations: is there really a therapeutic range?
Topics: Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Doxepin; Female; Germany; Health Knowle | 2001 |
Doxepin plasma concentrations: is there really a therapeutic range?
Topics: Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Doxepin; Female; Germany; Health Knowle | 2001 |
[Tricyclic antidepressants as inhibitors of brain glutathione-S-transferase].
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Autopsy; Binding Sites; Brain; Clomipramine; Depres | 2001 |
[Tricyclic antidepressants as inhibitors of brain glutathione-S-transferase].
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Autopsy; Binding Sites; Brain; Clomipramine; Depres | 2001 |
The effect of fluoxetine in depression associated with multiple sclerosis.
Topics: Adult; Cognition Disorders; Depressive Disorder; Doxepin; Female; Fluoxetine; Humans; Multiple Scler | 1992 |
The effect of fluoxetine in depression associated with multiple sclerosis.
Topics: Adult; Cognition Disorders; Depressive Disorder; Doxepin; Female; Fluoxetine; Humans; Multiple Scler | 1992 |
Effects of carbamazepine on serum antidepressant concentrations in psychiatric patients.
Topics: Adult; Age Factors; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Depressiv | 1991 |
Effects of carbamazepine on serum antidepressant concentrations in psychiatric patients.
Topics: Adult; Age Factors; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Depressiv | 1991 |
Is doxepin a safer tricyclic for the heart?
Topics: Aged; Arrhythmias, Cardiac; Blood Pressure; Depressive Disorder; Dose-Response Relationship, Drug; D | 1991 |
Is doxepin a safer tricyclic for the heart?
Topics: Aged; Arrhythmias, Cardiac; Blood Pressure; Depressive Disorder; Dose-Response Relationship, Drug; D | 1991 |
Tricyclics and heart failure.
Topics: Aged; Depressive Disorder; Doxepin; Heart Failure; Humans; Male; Myocardial Contraction; Nortriptyli | 1991 |
Tricyclics and heart failure.
Topics: Aged; Depressive Disorder; Doxepin; Heart Failure; Humans; Male; Myocardial Contraction; Nortriptyli | 1991 |
Prediction of steady-state plasma levels of doxepin and imipramine from single dose levels in depressed outpatients.
Topics: Adolescent; Adult; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Doxepin; | 1991 |
Prediction of steady-state plasma levels of doxepin and imipramine from single dose levels in depressed outpatients.
Topics: Adolescent; Adult; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Doxepin; | 1991 |
Cis- and trans-isomers of doxepin and desmethyldoxepin in the plasma of depressed patients treated with doxepin.
Topics: Chromatography, Gas; Depressive Disorder; Doxepin; Humans; Stereoisomerism | 1990 |
Cis- and trans-isomers of doxepin and desmethyldoxepin in the plasma of depressed patients treated with doxepin.
Topics: Chromatography, Gas; Depressive Disorder; Doxepin; Humans; Stereoisomerism | 1990 |
Rhabdomyolysis in a depressed patient following overdose with combined drug therapy and alcohol.
Topics: Adult; Alcoholic Intoxication; Depressive Disorder; Diazepam; Doxepin; Fluoxetine; Humans; Male; Rha | 1990 |
Rhabdomyolysis in a depressed patient following overdose with combined drug therapy and alcohol.
Topics: Adult; Alcoholic Intoxication; Depressive Disorder; Diazepam; Doxepin; Fluoxetine; Humans; Male; Rha | 1990 |
Doxepin-induced cardiac dysrhythmia.
Topics: Adult; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Depressive Disorder; Doxepin; Female; Hea | 1988 |
Doxepin-induced cardiac dysrhythmia.
Topics: Adult; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Depressive Disorder; Doxepin; Female; Hea | 1988 |
Comparative plasma levels of doxepin and desipramine in the elderly.
Topics: Administration, Oral; Aged; Aged, 80 and over; Depressive Disorder; Desipramine; Dose-Response Relat | 1989 |
Comparative plasma levels of doxepin and desipramine in the elderly.
Topics: Administration, Oral; Aged; Aged, 80 and over; Depressive Disorder; Desipramine; Dose-Response Relat | 1989 |
Depression-dependent exacerbation of tardive dyskinesia.
Topics: Depressive Disorder; Doxepin; Dyskinesia, Drug-Induced; Electroconvulsive Therapy; Female; Follow-Up | 1989 |
Depression-dependent exacerbation of tardive dyskinesia.
Topics: Depressive Disorder; Doxepin; Dyskinesia, Drug-Induced; Electroconvulsive Therapy; Female; Follow-Up | 1989 |
Antidepressants and cessation of smoking.
Topics: Antidepressive Agents; Depressive Disorder; Doxepin; Humans; Smoking Prevention; Tobacco Use Disorde | 1989 |
Antidepressants and cessation of smoking.
Topics: Antidepressive Agents; Depressive Disorder; Doxepin; Humans; Smoking Prevention; Tobacco Use Disorde | 1989 |
A case of immune complex hemolytic anemia, thrombocytopenia, and acute renal failure associated with doxepin use.
Topics: Acute Kidney Injury; Anemia, Hemolytic, Autoimmune; Depressive Disorder; Doxepin; Humans; Male; Midd | 1989 |
A case of immune complex hemolytic anemia, thrombocytopenia, and acute renal failure associated with doxepin use.
Topics: Acute Kidney Injury; Anemia, Hemolytic, Autoimmune; Depressive Disorder; Doxepin; Humans; Male; Midd | 1989 |
[Psychopathologic prediction of ambulatory doxepin response. A replication trial].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Depressive Disorder; Doxepin; Female; Humans; Male; Middle | 1988 |
[Psychopathologic prediction of ambulatory doxepin response. A replication trial].
Topics: Adolescent; Adult; Aged; Ambulatory Care; Depressive Disorder; Doxepin; Female; Humans; Male; Middle | 1988 |
A replication study for the prediction of doxepine-response in depressed outpatients.
Topics: Depressive Disorder; Doxepin; Humans; Outpatients; Psychiatric Status Rating Scales | 1988 |
A replication study for the prediction of doxepine-response in depressed outpatients.
Topics: Depressive Disorder; Doxepin; Humans; Outpatients; Psychiatric Status Rating Scales | 1988 |
The jitteriness syndrome in panic disorder patients treated with antidepressants.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Diso | 1988 |
The jitteriness syndrome in panic disorder patients treated with antidepressants.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Diso | 1988 |
Tricyclic antidepressant blood levels.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Doxepin; Female; Humans; Male | 1988 |
Tricyclic antidepressant blood levels.
Topics: Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Doxepin; Female; Humans; Male | 1988 |
Dystonic reactions to amitriptyline and doxepin.
Topics: Adult; Amitriptyline; Basal Ganglia Diseases; Depressive Disorder; Doxepin; Dystonia; Female; Humans | 1988 |
Dystonic reactions to amitriptyline and doxepin.
Topics: Adult; Amitriptyline; Basal Ganglia Diseases; Depressive Disorder; Doxepin; Dystonia; Female; Humans | 1988 |
Doxepin-cholestyramine interaction.
Topics: Aged; Cholestyramine Resin; Depressive Disorder; Doxepin; Drug Interactions; Humans; Male | 1988 |
Doxepin-cholestyramine interaction.
Topics: Aged; Cholestyramine Resin; Depressive Disorder; Doxepin; Drug Interactions; Humans; Male | 1988 |
Selected tricyclic antidepressants in the management of chronic benign pain.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Chronic Disease; Depressive Disorder; Doxepin; Huma | 1988 |
Selected tricyclic antidepressants in the management of chronic benign pain.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Chronic Disease; Depressive Disorder; Doxepin; Huma | 1988 |
Combined drug therapy for an elderly depressed patient.
Topics: Aged; Depressive Disorder; Doxepin; Drug Therapy, Combination; Female; Humans; Lithium; Phenelzine | 1988 |
Combined drug therapy for an elderly depressed patient.
Topics: Aged; Depressive Disorder; Doxepin; Drug Therapy, Combination; Female; Humans; Lithium; Phenelzine | 1988 |
Five to fifteen years' maintenance doxepin therapy.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Depressive Disorder; Doxepin; Drug Interactions; Fe | 1986 |
Five to fifteen years' maintenance doxepin therapy.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Depressive Disorder; Doxepin; Drug Interactions; Fe | 1986 |
Profound hypoglycemia with the addition of a tricyclic antidepressant to maintenance sulfonylurea therapy.
Topics: Aged; Chlorpropamide; Depressive Disorder; Diabetes Complications; Diabetes Mellitus; Doxepin; Drug | 1987 |
Profound hypoglycemia with the addition of a tricyclic antidepressant to maintenance sulfonylurea therapy.
Topics: Aged; Chlorpropamide; Depressive Disorder; Diabetes Complications; Diabetes Mellitus; Doxepin; Drug | 1987 |
Acupuncture and myofascial pain: treatment failure after administration of tricyclic antidepressants.
Topics: Acupuncture Therapy; Depressive Disorder; Doxepin; Endorphins; Female; Humans; Hyperalgesia; Middle | 1986 |
Acupuncture and myofascial pain: treatment failure after administration of tricyclic antidepressants.
Topics: Acupuncture Therapy; Depressive Disorder; Doxepin; Endorphins; Female; Humans; Hyperalgesia; Middle | 1986 |
Trazodone-induced mania.
Topics: Alcoholism; Bipolar Disorder; Depressive Disorder; Doxepin; Humans; Male; Middle Aged; Trazodone | 1987 |
Trazodone-induced mania.
Topics: Alcoholism; Bipolar Disorder; Depressive Disorder; Doxepin; Humans; Male; Middle Aged; Trazodone | 1987 |
Antidepressant treatment of medical-surgical inpatients by nonpsychiatric physicians.
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents; Chronic Disease; Depressive Di | 1987 |
Antidepressant treatment of medical-surgical inpatients by nonpsychiatric physicians.
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents; Chronic Disease; Depressive Di | 1987 |
Patient with chronic and apparently treatment-resistant dysthymia.
Topics: Adult; Amoxapine; Antidepressive Agents; Chronic Disease; Depressive Disorder; Doxepin; Humans; Male | 1986 |
Patient with chronic and apparently treatment-resistant dysthymia.
Topics: Adult; Amoxapine; Antidepressive Agents; Chronic Disease; Depressive Disorder; Doxepin; Humans; Male | 1986 |
Excretion of doxepin and N-desmethyldoxepin in human milk.
Topics: Adult; Breast Feeding; Depressive Disorder; Doxepin; Female; Humans; Infant; Milk, Human | 1985 |
Excretion of doxepin and N-desmethyldoxepin in human milk.
Topics: Adult; Breast Feeding; Depressive Disorder; Doxepin; Female; Humans; Infant; Milk, Human | 1985 |